ABSTRACT The aim of this research work was to Evaluation of Some Natural Polymer used as Sustained Release Matrix Tablet, any pharmaceutical formulation contains two ingredients one is the active ingredient and other is an excipients. An excipients help in the manufacturing of dosage form and it also improves physicochemical parameters of the dosage form. Polymers play an important role as excipients in any dosage form. They influence drug release and should be compatible, non-toxic, stable, economic etc. and develop a fixed Dose Combination product in a two different strength using same blend for both the strengths of tablet as a SR tablet formulation. In the tablet, Extended Release layer consist of Antihypertensive Drug belonging to cla...
The objective of present work was to design and develop sustained release matrix tablets of anti-hyp...
Angiotensin-II receptor blocker losartan, approved by the FDA in 1995, is used to treat hypertension...
The aim of the present study was to develop a controlled porosity osmotic tablet of Losartan potassi...
The present study is to prepare and evaluate controlled release matrix tablets of Losartan potassium...
Sustained release matrix tablets of 100 mg losartan potassium HCl were fabricated with two release r...
The present study was aimed towards the development of controlled release formulations of Losartan P...
The objective of the present study was to develop hydrophilic polymer and hydrophobic polymer based ...
The main aim of present work was to formulate and evaluate sustain release matrix tablets of Losarta...
The main aim of the study formulation and evaluation of the lornoxicam sustained release tablets by ...
The purpose of present study was to develop once a day sustained release matrix tablet of Quetiapine...
The main aim of this investigation was to develop a sustained release matrix tablets of Tramadol HCl...
Osmotically controlled oral drug delivery systems utilize osmotic pressure as energy source for the ...
Osmotically controlled oral drug delivery systems utilize osmotic pressure as energy source for the ...
In Conclusion, the aim of the present study was to develop mucoadhesive drug delivery system for Los...
ABSTRACT: The present work is regarding formulation, development and evaluation of losartan potassiu...
The objective of present work was to design and develop sustained release matrix tablets of anti-hyp...
Angiotensin-II receptor blocker losartan, approved by the FDA in 1995, is used to treat hypertension...
The aim of the present study was to develop a controlled porosity osmotic tablet of Losartan potassi...
The present study is to prepare and evaluate controlled release matrix tablets of Losartan potassium...
Sustained release matrix tablets of 100 mg losartan potassium HCl were fabricated with two release r...
The present study was aimed towards the development of controlled release formulations of Losartan P...
The objective of the present study was to develop hydrophilic polymer and hydrophobic polymer based ...
The main aim of present work was to formulate and evaluate sustain release matrix tablets of Losarta...
The main aim of the study formulation and evaluation of the lornoxicam sustained release tablets by ...
The purpose of present study was to develop once a day sustained release matrix tablet of Quetiapine...
The main aim of this investigation was to develop a sustained release matrix tablets of Tramadol HCl...
Osmotically controlled oral drug delivery systems utilize osmotic pressure as energy source for the ...
Osmotically controlled oral drug delivery systems utilize osmotic pressure as energy source for the ...
In Conclusion, the aim of the present study was to develop mucoadhesive drug delivery system for Los...
ABSTRACT: The present work is regarding formulation, development and evaluation of losartan potassiu...
The objective of present work was to design and develop sustained release matrix tablets of anti-hyp...
Angiotensin-II receptor blocker losartan, approved by the FDA in 1995, is used to treat hypertension...
The aim of the present study was to develop a controlled porosity osmotic tablet of Losartan potassi...